Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.
about
A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinomaCXCR4 over-expression and survival in cancer: a system review and meta-analysisInhibitory effects and underlying mechanism of 7-hydroxyflavone phosphate ester in HeLa cellsThe role of chemoattractant receptors in shaping the tumor microenvironment.Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines.Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus.Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinomaCXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.The intricate role of CXCR4 in cancer.Multiscale computational models in physical systems biology of intracellular trafficking.Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells.Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does notInterstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK SignalingAlpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells.Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver CancerHepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma CellsDifferential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.Targeted therapy of hepatocellular cancer.Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells.MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinomaThe peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets.Bone metastases in hepatocellular carcinoma: an emerging issue.Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinoma.Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.Diverse Functions and Signal Transduction of the Exocyst Complex in Tumor Cells.Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells.Stemness-related transcriptional factors and homing gene expression profiles in hepatic differentiation and cancer.A clinicopathological model to predict bone metastasis in hepatocellular carcinoma.N-[11C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs.Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential.Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.Localized delivery of chemokine for in vitro manipulation of hepatocellular carcinoma cell behaviors during the epithelial-mesenchymal transition.Microarray analysis for the identification of specific proteins and functional modules involved in the process of hepatocellular carcinoma originating from cirrhotic liver.CXCR4 Expression in Gastric Cancer and Bone Marrow: Association with Hypoxia-Regulated Indices, Disseminated Tumor Cells, and Patients Survival
P2860
Q26800288-C79AB9A1-7736-411A-804F-733BF880A4D5Q28084663-23526402-F4DD-40B8-9C1E-897F95438067Q28483410-FE1C5BFD-8003-4BE5-BDC2-4E3D3917629FQ33993124-F39B4C82-14B2-4400-8B73-FF4C9903B65BQ34016378-35F97C24-2804-40F9-9092-8A1B68878228Q34408178-CB106BA1-FF37-48E5-8C48-A86E1FE0A8ACQ34614290-F16DF295-DE43-46A1-9FC4-D655E0BA4FD4Q35012653-3F4D5CDC-3839-4FEE-9A00-C1297E9832C1Q35067624-850E62B1-F563-4ABA-B31B-798D1043B51BQ35106771-DF703AE1-C702-4B36-8E8B-3A4E689577E1Q35124198-4B7BAC6E-E4C3-40C1-97FC-E528D6B137EBQ35584655-F80B6F73-3D7B-4618-BF78-293EB6B48EB4Q35787278-E44BA300-A862-470C-BE2A-BC68DE958BFAQ35833601-094AF889-B1F1-4F11-9982-8CE52EA0F22FQ36271326-20C27B09-1631-4D3D-975B-6217F7A3285FQ36595263-DF1E615A-68B5-466E-A055-33250281B3ACQ36757178-014687B5-DA19-4B54-B873-525D7B2B3793Q37012048-A7BC1A51-2BEA-443F-9416-71909C446E20Q37666058-AE8FC062-8C00-4C41-896D-105FBE0BF10DQ37674624-9C622F48-1A33-40F0-824A-CB232D0D5F8CQ37689017-30EB4AB9-EA44-4F6F-BA90-D3FCA8BDCBC9Q37699408-D95D2418-3BDC-4E8E-B8BB-145B8AF12A3EQ38167634-9A131350-CD00-4CB7-BDD9-98A054CC7526Q38172848-439B8929-C4DE-4227-8EE9-7D73AE8FEC98Q38235254-1FD6F615-8776-4689-9063-2FF7FD31183DQ38645374-EBC1916C-E213-4F33-953B-CA403286F172Q38867913-0F9AFDD4-3B5F-4A31-961B-6BF64FD47FF8Q38964621-2B167C50-0214-4964-BACB-D6025F514EFBQ39154317-53B26CF6-00E8-4ED4-A026-0FFBF2C0A01EQ39395370-11B8C9FF-B6F9-4AAB-9CFC-5E2F3A2603F0Q39707910-DBB15F3B-9285-40A3-9898-A843199A43A2Q40956635-19353C6E-150A-4205-B94F-6510702A5B22Q42125248-B0CC08F2-EE5C-436D-B96C-97E496CEA4E8Q47135284-309B3AC7-3D70-4408-A74D-9E9D6D2E2E99Q49330451-11573A96-3847-4F6F-A307-E6C6758F6FAAQ50047802-8C4D726C-BA31-4879-BB4B-51A329812AB7Q59104388-149A13F1-807B-41D4-A84A-8E2EC15D2942
P2860
Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Chemokine receptor CXCR4 expre ...... metastases and poor survival.
@ast
Chemokine receptor CXCR4 expre ...... metastases and poor survival.
@en
type
label
Chemokine receptor CXCR4 expre ...... metastases and poor survival.
@ast
Chemokine receptor CXCR4 expre ...... metastases and poor survival.
@en
prefLabel
Chemokine receptor CXCR4 expre ...... metastases and poor survival.
@ast
Chemokine receptor CXCR4 expre ...... metastases and poor survival.
@en
P2093
P2860
P356
P1433
P1476
Chemokine receptor CXCR4 expre ...... metastases and poor survival.
@en
P2093
Peng-Yuan Zhuang
Ying Liang
Yun-Shan Tan
Zhao-Chong Zeng
Zhao-You Tang
Zuo-Lin Xiang
P2860
P2888
P356
10.1186/1471-2407-9-176
P407
P577
2009-06-09T00:00:00Z
P5875
P6179
1009206163